The investigations reported that these ultra-small NPs exhibited remarkable potential to inhibit AChE activity, highlighting important implications and firmly positioning the synthesized NPs as a promising candidate with considerable therapeutic potential in Alzheimer’s disease (AD) therapy. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.